NCT07818005

Brief Summary

This retrospective study evaluates the real-world effect of individualized glycemic response-guided dietary management, based on continuous glucose monitoring (CGM), on weight and body composition in overweight and obese university students. All data for this analysis were retrospectively retrieved from the archived records of a randomized controlled trial conducted at He University, in which 60 students (body mass index \[BMI\] ≥ 24 kg/m² or elevated body fat percentage) had worn CGM sensors for 4 weeks. The archived records show that the exposed group (n = 30) had received individualized dietary guidance generated from their own glucose responses, including structured CGM reports, meal composition and eating-order advice, and standardized feedback, whereas the non-exposed group (n = 30) had worn CGM without receiving any dietary guidance. One non-exposed participant was excluded from this retrospective analysis for missing primary outcome data, leaving 59 participants for analysis. The archived dataset contains body composition (weight, body mass index \[BMI\], body fat mass, percent body fat, skeletal muscle mass, visceral fat level) and eating behavior records at Day 0, Day 28, and Day 90. This analysis examines whether the 4-week intervention produced sustained, fat-mass-driven improvements in body composition and whether changes in eating behavior mediated these effects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 27, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2026

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2026

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

August 25, 2026

Completed
20 days until next milestone

First Posted

Study publicly available on registry

September 14, 2026

Completed
Last Updated

September 14, 2026

Status Verified

August 1, 2026

Enrollment Period

1 month

First QC Date

August 25, 2026

Last Update Submit

September 8, 2026

Conditions

Keywords

continuous glucose monitoringpersonalized nutritionbody compositioneating behavioruniversity studentsretrospective study

Outcome Measures

Primary Outcomes (2)

  • Time above range (TAR)

    Change in the percentage of time above the target glucose range recorded in the archived CGM dataset. Unit of Measure: Percent of time (%).

    Data recorded at baseline, Day 14, and Day 28

  • Body weight

    Change in body weight recorded in the archived InBody 120 dataset. Unit of Measure: Kilogram (kg).

    Data recorded at Day 0, Day 28, and Day 90

Secondary Outcomes (31)

  • Body fat mass

    Data recorded at Day 0, Day 28, and Day 90

  • Body mass index (BMI)

    Data recorded at Day 0, Day 28, and Day 90

  • Percent body fat

    Data recorded at Day 0, Day 28, and Day 90

  • Skeletal muscle mass

    Data recorded at Day 0, Day 28, and Day 90

  • Visceral fat level

    Data recorded at Day 0, Day 28, and Day 90

  • +26 more secondary outcomes

Study Arms (2)

Exposed (n=30)

Participants whose archived records from the parent trial indicate that they had received a 4-week individualized glycemic response-guided dietary intervention based on continuous glucose monitoring (CGM) data: dietary behavior observation during weeks 1-2, followed by structured CGM reports, dietary guidance on meal composition and eating order, and standardized researcher feedback during weeks 3-4.

Non-exposed (n=29)

Participants whose archived records from the parent trial indicate that they had worn the CGM system for 4 weeks without receiving dietary guidance or feedback. CGM data were visible during weeks 1-2 and blinded during weeks 3-4. Participants maintained their usual diet and lifestyle. One of the 30 non-exposed participants enrolled in the parent trial was excluded from this retrospective analysis for missing primary outcome data.

Eligibility Criteria

Age18 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Overweight and obese university students (aged 18-25 years) at He University, Shenyang, Liaoning, China, whose records are contained in the archived dataset of a randomized controlled trial of a 4-week continuous glucose monitoring (CGM)-guided personalized dietary intervention. Participants had a body mass index (BMI) ≥ 24 kg/m² or elevated body fat percentage (≥ 25% in men, ≥ 32% in women) and self-reported at least two unhealthy eating behaviors. Of the 60 participants enrolled in the parent trial (30 per group), 59 were included in this retrospective analysis (30 exposed, 29 non-exposed); one non-exposed participant was excluded for missing primary outcome data. All participants were free of diabetes, prediabetes, and other exclusion conditions defined in the study protocol.

You may qualify if:

  • University students aged 18 to 25 years
  • Body mass index (BMI) ≥ 24.0 kg/m², or body fat percentage ≥ 25% (male) / ≥ 32% (female)
  • Self-reported presence of at least two unhealthy eating behaviors
  • Written informed consent

You may not qualify if:

  • Polycystic ovary syndrome (PCOS)
  • Weight gain or glycemic abnormality induced by medications (e.g., glucocorticoids, antipsychotics, insulin secretagogues)
  • Diagnosed diabetes (type 1 or type 2) or prediabetes (fasting glucose ≥ 6.1 mmol/L or glycated hemoglobin (HbA1c)≥ 5.7%)
  • Diagnosed dyslipidemia with lipid-lowering medication
  • High risk of eating disorders identified by the Eating Disorder Diagnostic Scale (EDDS)
  • Severe psychiatric disorders or psychotropic medication use
  • Pregnancy, lactation, or planned pregnancy within 6 months
  • Allergy to CGM adhesive or hydrogel, or active skin disease affecting sensor wear
  • Professional athletes (high-intensity physical activity ≥ 5 times/week, ≥ 60 min/session)
  • Weight change \> 5% of initial body weight within the past 3 months
  • Participation in other commercial or clinical weight-loss programs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

He University, Shenyang, Liaoning, China

Shenyang, Liaoning, China

Location

MeSH Terms

Conditions

OverweightObesityWeight LossFeeding Behavior

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight ChangesBehavior, AnimalBehavior

Study Officials

  • Jun Li, MD

    He University, Shenyang, Liaoning, China

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 25, 2026

First Posted

September 14, 2026

Study Start

June 27, 2026

Primary Completion

July 30, 2026

Study Completion

August 15, 2026

Last Updated

September 14, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations